What is SLU-PP-915?

Molecular Mechanism and Metabolic Research Overview

SLU-PP-915 is a synthetic research compound studied as a pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ). These nuclear receptors play a central role in regulating cellular energy metabolism, mitochondrial activity, and adaptive metabolic processes.

The compound was developed through structure-based optimization to improve metabolic stability and systemic availability in experimental models. It represents a newer generation of ERR-targeting molecules designed to coordinate metabolic signaling at the transcriptional level.

As of 2026, SLU-PP-915 remains a research-use compound. No human clinical trials have been reported, and all available data originate from preclinical research, including in vitro systems, ex vivo tissues, and controlled animal models.

Understanding Estrogen-Related Receptors (ERRs)

Estrogen-related receptors (ERRs) are ligand-activated nuclear receptors involved in the regulation of metabolic gene expression. They influence pathways associated with:

• mitochondrial energy production
• oxidative metabolism
• fatty acid utilization
• cellular adaptation to energy demand

ERR signaling is highly active in metabolically demanding tissues such as skeletal muscle, cardiac tissue, and liver, where energy regulation and mitochondrial efficiency are essential.

SLU-PP-915 is studied for its ability to activate all three ERR isoforms simultaneously, making it a relevant compound in research exploring coordinated metabolic regulation and system-level energy balance.

Molecular Mechanism of Action

At the molecular level, SLU-PP-915 functions as a ligand that binds to the ligand-binding domain (LBD) of ERR receptors.

Ligand binding induces conformational changes in the receptor structure, promoting recruitment of transcriptional coactivators such as PGC-1α, a key regulator of mitochondrial biogenesis and oxidative metabolism.

This interaction leads to activation of ERR-dependent transcription at ERR response elements (ERREs), influencing gene networks involved in energy production, substrate utilization, and cellular adaptation.

The result is coordinated modulation of metabolic pathways that regulate how cells generate, store, and utilize energy.

Key Pathways Studied

Mitochondrial Biogenesis and Energy Production

SLU-PP-915 is associated with activation of pathways involved in mitochondrial function and oxidative phosphorylation (OXPHOS).

These include processes related to:

• electron transport chain activity
• tricarboxylic acid (TCA) cycle function
• ATP generation and energy turnover

This makes the compound relevant in research focused on mitochondrial efficiency and cellular energy dynamics.

Fatty Acid Oxidation and Metabolic Reprogramming

In experimental models, SLU-PP-915 is linked to increased expression of genes involved in fatty acid oxidation (FAO).

These pathways are associated with shifts in substrate utilization, where cells preferentially rely on fatty acids as an energy source, supporting metabolic flexibility and energy adaptation under varying conditions.

Exercise-Mimetic Signaling

SLU-PP-915 is frequently studied in the context of exercise-related signaling pathways.

It is associated with activation of transcriptional programs that resemble those observed during endurance activity, particularly in skeletal muscle models.

These programs are linked to enhanced mitochondrial gene expression, oxidative metabolism, and energy utilization pathways.

Autophagy and Cellular Maintenance

The compound is also examined in relation to autophagy, a cellular process responsible for maintaining cellular integrity through recycling of damaged components.

This includes activation of TFEB and lysosomal gene networks, associated with:

• cellular turnover processes
• organelle recycling
• maintenance of metabolic homeostasis

These pathways are central to cellular quality control and long-term metabolic stability.

Integration of Metabolic Signaling

SLU-PP-915 is often studied within the broader context of integrated metabolic signaling networks.

ERR activation interacts with multiple regulatory systems, including:

• PGC-1α-driven mitochondrial signaling
• AMPK-mediated energy sensing
• redox balance and NAD⁺-dependent pathways

These interconnected systems regulate how cells respond to energy demand, environmental stress, and metabolic shifts over time.

Role of ERR Signaling in Tissue Function

Research indicates that ERR signaling plays a central role in mediating the biological effects associated with SLU-PP-915.

These pathways are particularly relevant in:

• skeletal muscle metabolism
• cardiac energy regulation
• systemic metabolic coordination
• cellular stress response mechanisms

Gene expression analyses suggest that a significant portion of observed transcriptional changes are dependent on ERR-mediated signaling pathways.

Preclinical Research Overview

Exercise and Endurance Models

In controlled animal models, SLU-PP-915 is studied in relation to endurance capacity and metabolic performance.

Experimental observations are associated with activation of mitochondrial and oxidative metabolic pathways linked to sustained energy production.

Cardiac and Metabolic Research Models

In cardiovascular-focused studies, SLU-PP-915 is examined for its influence on metabolic gene expression and mitochondrial function within cardiac tissue.

These models investigate how energy regulation systems operate under conditions of increased physiological demand.

Cellular and In Vitro Studies

In cell-based systems, SLU-PP-915 is associated with:

• mitochondrial activity
• fatty acid metabolism
• autophagy-related signaling

These observations are studied in the context of cellular adaptation, metabolic regulation, and signaling network integration.

Summary

SLU-PP-915 is a synthetic pan-ERR agonist studied in experimental models for its role in regulating cellular energy metabolism and mitochondrial function.

Its research profile is associated with:

• mitochondrial biogenesis and oxidative metabolism
• fatty acid utilization and metabolic flexibility
• exercise-related signaling pathways
• autophagy and cellular maintenance

As a research compound, SLU-PP-915 is used in preclinical studies to explore complex metabolic systems, energy regulation, and cellular adaptation processes.

Research Use Notice

All information presented is based on experimental and preclinical research data and is intended strictly for scientific and educational purposes.
This compound is supplied for research use only.

Explore the Product

SLU-PP-915 100 mg – Research-Grade Metabolic Signaling Compound